Skip to content
Nonprofiteer
← GLIOBLASTOMA FOUNDATION INC

Form 990 for tax year 2024

Filed by GLIOBLASTOMA FOUNDATION INC.

Totals

Total revenue
$2,055,218
Total expenses
$1,833,664
Contributions and grants received
$1,964,537
Grants paid
$97,474
Program service revenue
$0
Investment income
$2,803
Other revenue
$87,878
Total assets, end of year
$3,662,658
Total liabilities, end of year
$496,171
Net assets or fund balances, end of year
$3,166,487
Program services expenses (Part IX)
$1,581,752
Management and general expenses
$237,982
Fundraising expenses
$13,930
Program service expenses (Part III)
$1,581,752

Program services were 86.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $1,964,537

  • 3 · Investment income

    total $22,886 · excluded $22,886

  • 7a · Gross sales of assets other than inventory

    securities $121,652

  • 7b · Less cost or other basis and sales expenses

    securities $141,735

  • 7c · Gain or loss

    securities -$20,083

  • 7d · Net gain or loss

    total -$20,083 · excluded -$20,083

  • 8a · Fundraising events: gross income

    $142,000

  • 8b · Fundraising events: direct expenses

    $54,122

  • 8c · Net income from fundraising events

    total $87,878 · excluded $87,878

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $97,474 · program services $97,474

  • 5 · Compensation of officers, directors and key employees

    total $343,048 · program services $325,896 · management and general $10,291 · fundraising $6,861

  • 7 · Other salaries and wages

    total $313,484 · program services $297,809 · management and general $9,405 · fundraising $6,270

  • 10 · Payroll taxes

    total $39,943 · program services $37,946 · management and general $1,198 · fundraising $799

  • 11b · Fees: legal

    total $109,886 · management and general $109,886

  • 11c · Fees: accounting

    total $33,284 · management and general $33,284

  • 12 · Advertising and promotion

    total $328,033 · program services $328,033

  • 13 · Office expenses

    total $22,945 · management and general $22,945

  • 14 · Information technology

    total $15,734 · program services $15,734

  • 17 · Travel

    total $69,379 · program services $69,379

  • 19 · Conferences, conventions and meetings

    total $21,601 · program services $21,601

  • 20 · Interest

    total $3,328 · program services $3,328

  • 22 · Depreciation, depletion and amortization

    total $56,674 · program services $54,407 · management and general $2,267

  • 23 · Insurance

    total $3,874 · program services $3,874

  • 24a · Other expenses: FACILITIES AND EQUIPMEN

    total $211,652 · program services $211,652

  • 24b · Other expenses: CONTRACT SERVICES

    total $77,821 · program services $77,821

  • 24c · Other expenses: RESEARCH EXPENSE

    total $36,798 · program services $36,798

  • 24d · Other expenses: MISCELLANEOUS

    total $14,695 · management and general $14,695

  • 24e · All other expenses

    total $34,011 · management and general $34,011

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $1,025,929 · end of year $611,752

  • 3 · Pledges and grants receivable

    beginning of year $18,250 · end of year $10,920

  • 10a · Land, buildings and equipment: cost or other basis

    $156,360

  • 10b · Land, buildings and equipment: accumulated depreciation

    $8,947

  • 10c · Land, buildings and equipment, net

    beginning of year $6,267 · end of year $147,413

  • 12 · Investments: other securities

    beginning of year $1,431,580 · end of year $2,246,251

  • 14 · Intangible assets

    beginning of year $0 · end of year $259,450

  • 15 · Other assets

    beginning of year $0 · end of year $386,872

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $142,529

  • 25 · Other liabilities

    beginning of year $0 · end of year $353,642

  • 27 · Net assets without donor restrictions

    beginning of year $2,482,026 · end of year $3,166,487

Mission and programs · 2024

Mission

THE GLIOBLASTOMA FOUNDATION IS DEDICATED TO FINDING A CURE FOR GLIOBLASTOMA BY FUNDING RESEARCH AND DRUG DEVELOPMENT, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS DEVASTATING BRAIN CANCER. THROUGH THESE INTEGRATED PROGRAMS, THE FOUNDATION ACCELERATES SCIENTIFIC DISCOVERY, EMPOWERS PATIENTS WITH INFORMATION AND RESOURCES, AND EDUCATES THE PUBLIC ABOUT THE URGENT NEED FOR BETTER TREATMENTS AND IMPROVED OUTCOMES.

Activities or mission (Part I)

TO IMPROVE TREATMENT OPTIONS FOR GLIOBLASTOMA PATIENTS BY FUNDING INNOVATIVE RESEARCH, EXPANDING ACCESS TO GENOMIC TESTING, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS AGGRESSIVE BRAIN CANCER.

  • RESEARCH AND DRUG DEVELOPMENT:IN 2024, THE GLIOBLASTOMA FOUNDATION ADVANCED ITS RESEARCH MISSION BY ACQUIRING LISAVANBULIN, A PROMISING TARGETED THERAPY FROM BASILEA PHARMACEUTICA, FOR FURTHER CLINICAL DEVELOPMENT IN GLIOBLASTOMA. THIS ACQUISITION MARKED A CRITICAL STEP TOWARD BRINGING PATIENTS NEW, MORE EFFECTIVE TREATMENTS. THE FOUNDATION ALSO SUPPORTED INVESTIGATOR-INITIATED RESEARCH ON MOLECULAR CHARACTERIZATION AND FUNCTIONAL PRECISION ONCOLOGY. ADDITIONALLY, THE FOUNDATION ESTABLISHED GLIOLAB, A CLIA-REGISTERED GENOMIC LABORATORY THAT WILL PROVIDE STATE-OF-THE-ART TESTING TO ACCELERATE DISCOVERY OF TARGETED THERAPIES BASED ON EACH TUMOR'S GENOMIC AND EPIGENOMIC PROFILE.

    Expenses $527,251 · Grants $97,474

  • PATIENT SUPPORT AND EDUCATION:THROUGHOUT 2024, THE FOUNDATION PROVIDED SUPPORT SERVICES FOR GLIOBLASTOMA PATIENTS AND CAREGIVERS NATIONWIDE, INCLUDING PERSONALIZED CLINICAL-TRIAL MATCHING, PROFESSIONALLY LED VIRTUAL SUPPORT GROUPS, AND EDUCATIONAL RESOURCES ON TREATMENT OPTIONS AND EMERGING RESEARCH. THESE PROGRAMS EMPOWERED PATIENTS TO MAKE INFORMED CARE DECISIONS AND FOSTERED A SENSE OF COMMUNITY AMONG FAMILIES AFFECTED BY THIS RARE DISEASE. HUNDREDS OF PATIENTS AND CAREGIVERS BENEFITED FROM THESE FREE SERVICES DURING THE YEAR.

    Expenses $527,251

  • PUBLIC AWARENESS AND ADVOCACY:THE FOUNDATION LED NATIONWIDE EFFORTS TO RAISE AWARENESS AND ADVOCACY FOR THOSE AFFECTED BY GLIOBLASTOMA. IN 2024, IT ORGANIZED GLIOBLASTOMA AWARENESS DAY AND CONTINUED THE VOICES OF GLIOBLASTOMA PODCAST WHILE PLANNING TO EXPAND THE SERIES IN FUTURE YEARS TO FEATURE ADDITIONAL PATIENT, CAREGIVER, AND SCIENTIST PERSPECTIVES. THE FOUNDATION ALSO PARTNERED WITH EVENTS SUCH AS THE LOS ANGELES MARATHON TO INCREASE PUBLIC UNDERSTANDING AND SUPPORT FOR RESEARCH. THESE INITIATIVES EDUCATED THOUSANDS AND INSPIRED HOPE WITHIN THE GLIOBLASTOMA COMMUNITY.

    Expenses $527,250

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Neelam Kwatra

    PRESIDENT

    Total calculated
    $0
    Hours/week
    20

  • Madan Kwatra

    TREASURER/SECRETARY

    Total calculated
    $0
    Hours/week
    4

  • Gita Kwatra

    CEO

    Total calculated
    $343,048
    From this org
    $291,500
    From related orgs
    $0
    Other
    $51,548
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $291,500
    Bonus
    $0
    Other
    $0
    Deferred
    $23,000
    Nontaxable benefits
    $28,548
    Filer's total
    $343,048

  • Cameron West

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Brian Austin

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Provenance

Return type
form_990
Tax year
2024
Filed
17 November 2025
IRS schema version
2024v5.2
Source object
202503219349321800

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.